Dr. Bruce D. Forrest Joins Skymount Medical as Chief Medical Officer, Strengthening Team for Future Growth
June 22, 2022 10:15 ET
|
Skymount Medical, Inc.
CALGARY, Alberta and NEW ORLEANS, June 22, 2022 (GLOBE NEWSWIRE) -- Skymount Medical, a drug discovery company using a highly predictive artificial intelligence (AI) platform to repurpose and build...
Skymount Medical Wins Silver Stevie® Award for Its LSU-Developed DeepDrug™ Artificial Intelligence Platform to Accelerate Drug Discovery
May 31, 2022 08:00 ET
|
Skymount Medical, Inc.
CALGARY, Alberta and BATON ROUGE, La., May 31, 2022 (GLOBE NEWSWIRE) -- Skymount Medical, a drug discovery company using an artificial intelligence (AI) platform developed by Louisiana State...
Skymount Medical Receives UK MHRA Approval to Test New Treatment in Patients with Mild to Moderate COVID-19
February 22, 2022 08:00 ET
|
Skymount Medical, Inc.
-- MHRA grants permission for UK clinical trials for AI-discovered drug combination that reduces length and severity of symptoms and could lower hospitalizations -- -- Approval expands Skymount...